SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pharma stocks trade lower as Trump proposes steep tariff on generic drugs

22 Jul 2026 Evaluate

Pharmaceutical stocks were trading under pressure on the BSE after US President Donald Trump proposed tariffs of up to 200% on generic drug imports into the United States following a two-year tariff-free period.

Lupin is currently trading at Rs. 2422.75, down by 91.65 points or 3.65% from its previous closing of Rs. 2514.40 on the BSE. The scrip opened at Rs. 2498.90 and has touched a high and low of Rs. 2498.90 and Rs. 2410.05 respectively. So far 11765 shares were traded on the counter.

Aurobindo Pharma is currently trading at Rs. 1525.80, down by 54.65 points or 3.46% from its previous closing of Rs. 1580.45 on the BSE. The scrip opened at Rs. 1571.20 and has touched a high and low of Rs. 1571.20 and Rs. 1515.15 respectively. So far 41913 shares were traded on the counter.

Dr. Reddy's Laboratories is currently trading at Rs. 1187.70, down by 18.85 points or 1.56% from its previous closing of Rs. 1206.55 on the BSE. The scrip opened at Rs. 1199.65 and has touched a high and low of Rs. 1202.00 and Rs. 1184.10 respectively. So far 68187 shares were traded on the counter.

Lupin Share Price

2405.80 -108.60 (-4.32%)
22-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1942.95
Dr. Reddys Labs. 1183.00
Cipla 1415.10
Lupin 2405.80
Zydus Lifesciences 1129.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: